Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells

Signal transducer and activator of transcription-5 (Stat5) mediates prolactin (PRL)-induced differentiation and growth of breast epithelial cells. We have recently identified active Stat5 as a tumor marker of favorable prognosis in human breast cancer, and determined that Stat5 activation is lost during metastatic progression. Here we provide novel evidence for an invasion-suppressive role of Stat5 in human breast cancer. Activation of Stat5 by PRL in human breast cancer lines was associated with increased surface levels of the invasion-suppressive adhesion molecule E-cadherin in vitro and in xenotransplant tumors in vivo. Inducible E-cadherin was blocked by dominant-negative (Dn) Stat5 or Dn-Jak2, but not by Dn-Stat3. Further experimental data indicated a role of Stat5 as a coordinate regulator of additional invasion-related characteristics of human breast cancer cells, including cell surface association of β-catenin, homotypic cell clustering, invasion through Matrigel, cell migration, and matrix metalloproteinase activity. A role of Stat5 as a suppressor of breast cancer invasion and metastatic progression provides a biological mechanism to explain the favorable prognosis associated with active Stat5 in human breast cancer.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  S Parodi,et al.  Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor , 1987, The Journal of cell biology.

[3]  R. Kemler,et al.  Uvomorulin‐catenin complex: Cytoplasmic anchorage of a Ca2+‐dependent cell adhesion molecule , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.

[4]  N. Koshikawa,et al.  Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells. , 1992, Journal of biochemistry.

[5]  C. Der,et al.  Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia , 1995, The Journal of cell biology.

[6]  J. D. Greenwood,et al.  Cloning of the gene encoding rat JAK2, a protein tyrosine kinase. , 1995, Gene.

[7]  B. Groner,et al.  Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Rui,et al.  Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. , 1995, Endocrinology.

[9]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[10]  A. Sultan,et al.  Bisecting GlcNAc Structures Act as Negative Sorting Signals for Cell Surface Glycoproteins in Forskolin-treated Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.

[11]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[13]  W. Yu,et al.  Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.

[14]  A. Børresen-Dale,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .

[15]  H. Rui,et al.  A Lymphoma Growth Inhibitor Blocks Some but Not All Prolactin-stimulated Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[16]  C. Clevenger,et al.  Prolactin as a chemoattractant for human breast carcinoma. , 1999, Endocrinology.

[17]  K. Arihiro,et al.  Cytokines facilitate chemotactic motility of breast carcinoma cells , 2000, Breast cancer.

[18]  R. Foisner,et al.  E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity , 2001, The Journal of cell biology.

[19]  L. Hennighausen,et al.  Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium , 2001, The Journal of cell biology.

[20]  J. Xie,et al.  Role of Tyrosine Kinase Jak2 in Prolactin-induced Differentiation and Growth of Mammary Epithelial Cells* , 2002, The Journal of Biological Chemistry.

[21]  P. Furth,et al.  Loss of Stat5a delays mammary cancer progression in a mouse model , 2002, Oncogene.

[22]  R. Parton,et al.  Characterization of E-cadherin Endocytosis in Isolated MCF-7 and Chinese Hamster Ovary Cells , 2003, Journal of Biological Chemistry.

[23]  M. LeBaron,et al.  Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells* , 2003, Journal of Biological Chemistry.

[24]  J. Rosen,et al.  Signal Transduction Pathways Regulated by Prolactin and Src Result in Different Conformations of Activated Stat5b* , 2003, The Journal of Biological Chemistry.

[25]  E. Fearon.  Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. , 2003, Cancer cell.

[26]  T. Toyama,et al.  Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells , 2003, Oncogene.

[27]  Keith R. Johnson,et al.  Cadherins as modulators of cellular phenotype. , 2003, Annual review of cell and developmental biology.

[28]  H. Rui,et al.  Impaired Alveologenesis and Maintenance of Secretory Mammary Epithelial Cells in Jak2 Conditional Knockout Mice , 2004, Molecular and Cellular Biology.

[29]  J. Xie,et al.  Signal transducer and activator of transcription-5 activation and breast cancer prognosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.